A systematic review and meta-analysis of seroprevalence of SARS-CoV-2 in Africa
In a systemic review published in BMJ Global Health, Dr. Rahul Arora (University of Calgary) and the CITF-funded SeroTracker team estimates that seroprevalence in Africa (due to infection or vaccination) was 65.1% in July-September 2021.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
